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INPUD is a global constituency-based network of people who use 
illicit drugs, including people who are on pharmacotherapy pro-
grammes. We are committed to harm reduction, human rights 
and the meaningful participation of the drug using community 
in the development, implementation and monitoring of all poli-
cies, programmes, services, and initiatives that impact upon drug 
users lives. We aim to raise the voices and perspectives of the 
drug using community and its organisations in global advocacy 
spaces and processes. The network is committed to the principles 
sketched out in the Vancouver Declaration - ‘Nothing about us 
without us - a manifesto by people who use illegal drugs’ - and 
adheres to the following core principles in all of its advocacy, 
lobbying and capacity building work: 1) Pro drug user rights 2) 
Pro self-determination 3) Pro harm reduction and safer drug use 
4) Respecting the rights of people to use drugs or not 5) Anti-
prohibitionist 6) Pro equality.
 INPUD’s work sits within and helps to connect the larger 
drug user rights movement, a social movement fighting for the 
human rights, self-determination and equality of people who use 
drugs. Although there is still much to do to achieve this goal, 
activists within this movement have been at the forefront of chal-
lenging criminalising, prohibitive laws and policies in the face of 
oppression, marginalisation and widespread stigma. Successes 
have been tangible, for example in the form of harm reduction 
programmes, and also more abstract, for example encouraging a 
larger range of bodies to speak out in favour of drug policy reform 
and rethink taken-for-granted, discriminatory attitudes towards 
drug use. The ways that hard-won successes have been achieved, 
and the manifold challenges navigated and overcome, differs 
across the world, by region, by country, and by community. 
 INPUD and Rights Reporter Foundation have produced an 
original ten-part film series involving drug user advocates from 
around the world, providing their reflections on the drug user 
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rights movement. This film, Taking Back What’s Ours! An oral 
history of the movement of people who use drugs is being released 
as part of the HIV 2020 online conference. This accompanying 
qualitative research project, drawing on accounts from 34 activ-
ists across the globe, seeks to document the meanings that people 
who use drugs attribute to the movement, the challenges and ten-
sions they perceive working within and outside the movement, 
and strategies for effecting positive change. The report seeks to 
amplify the voices of leading advocates and identify common fea-
tures of the movement, while also paying attention to the influ-
ence of contextual factors that may facilitate or impede progress 
towards the movement’s goals. In doing so, this report aims to 
celebrate the movement’s strength and resilience despite the 
overwhelming challenges, and consider the lessons learned from 
a generation of pioneering activists that may inspire a newer gen-
eration to build upon and extend their successes.  
Methodology 
This report is based on semi-structured interviews conducted 
with 34 persons who use drugs, all leading activists/advocates 
for drug user rights, over the course of 8 months between 
September 2019 and May  2020. Fig. 1 shows the countries 
where participants have undertaken their activism activities, 
mindful that some participants now live in different countries, 
for example if they are working for a regional organisation or 
network. Interviews were conducted in English by interviewers 
based in the country of the participant with understanding of 
drug user activism; in certain cases, questions were asked in the 
participant’s preferred language, and the participant responded 
in English. 
 Questions covered: the participant’s involvement with the 
drug user rights movement, and impacts on the participant’s 
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personal life; lessons learnt from the participant’s career, in 
terms of successes achieved and overcoming challenges; and 
the participant’s views on criminalisation, the link between 
people who use drugs and the HIV/AIDS movement, and mes-
sages they might wish to share with previous or future genera-
tions of drug user rights advocates.
 Interviews were audio and video recorded, and transcribed. 
We conducted a thematic-style analysis of the transcripts. Firstly, 
we familiarised ourselves with participants’ accounts through 
reading of the transcript together with the audio recording. 
Then, interviews were coded, with a focus on the macro-level 
content of the account (i.e. the broader experiences and insights 
of participants, as opposed to nuances of language or discourse). 
After coding, comparison across interviews allowed for the gen-
eration of themes, under which findings are organised in the fol-
lowing sections. We also considered and noted insights and expe-
riences which differed from the overall direction of a theme, and 
some of these are discussed in the section on ‘The importance of 
context as an enabler or barrier to successful activism’.  
How do activists define  
the drug user rights movement? 
A fight for basic human rights
All participants without exception regard the fight for the 
respect, protection and fulfilment of the inalienable human 
rights of people who use drugs as a defining, fundamental fea-
ture of the drug user rights movement (hereafter referred to 
as ‘the movement’). The movement has promoted self-deter-
mination, the notion that “people who use drugs are people” 
(Angela), and the “upholding [of] human dignity” (Anand). 
Fundamentally, it is a “peace generating kind of movement” 
(Brun), born out of necessity, “passion” (Charles) and fighting 
for social justice for people who use drugs, at times when the 
scale of human rights violations in many countries has been 
staggering. Indeed, many participants became involved in 
movement after they or those close to them had experienced 
“life-threatening events” (Andria). The movement is about the 
rights to self-determination over one’s own body, decision-mak-
ing and consciousness. Furthermore, although participants 
phrased this more implicitly, the movement has also been con-
cerned with achieving broader economic, social and cultural 
rights for people who use drugs, such as the right to access 
appropriate, non-judgemental and non-coercive health ser-
vices, and safe housing. 
 The movement is not only about people who use drugs having 
access to the resources that society can offer, but also society 
having access to the resources that people who use drugs can 
offer; indeed, many participants highlighted the positive contri-
bution they have made to their communities and societies, and 
want people who use drugs to be welcomed as “resources” (Arild) 
for society rather than “scapegoated” (Jude) for societal prob-
lems. The movement is about being at the heart of decision-mak-
ing, and “meaningful involvement” (Simon) when policies are 
being made and implemented, in the spirit of ‘Nothing about us, 
without us.’1 
A movement fighting criminalisation and prohibition
Participants were unanimous that empowerment of people who 
use drugs and full respect for their rights can only be achieved 
by “dismantling prohibition” of drug use and drug possession 
(Jude). Criminalisation, and the repressive, oppressive laws and 
policies through which it is enacted, have been and continue 
to be at the root of all other harms and violations people who 
use drugs experience. Criminalisation of people who use drugs 
1. Canadian HIV/AIDS Legal Network (2005). “Nothing About Us Without Us”: A 




A source of empowerment, meaning and belonging
In the face of the “overwhelming oppression” (Annie) and “oth-
ering” (Jude) of people who use drugs, the movement is about 
empowerment, liberation, and fighting stigma, discrimination, 
and self-stigma at a time when being open about drug use can 
still come at a huge personal cost. 
 Discussing the impact of the movement on their personal life, 
many participants recounted painful rejection they had experi-
enced from their families and communities, especially when they 
were first open about their drug use. One participant’s family saw 
his activism as “amoral… and self-centred” (Simon). However, 
several participants’ families and communities had become 
much more “respectful” (Raheem) and “supportive” (Joergen) 
once the participants became more involved in activism. Other 
participants described how the movement itself has provided a 
family for its members, a “home… where I belong” (Annie), a 
union of “amongst the most talented, gifted and blessed indi-
viduals on the planet” (Robert). At the same time, some activ-
ists described a sense of ‘role conflict’ between supporting their 
immediate family and their community of people who use drugs, 
sometimes because of being “physically absent” (David) and “too 
busy” (Happy) due to their activism. 
 The sense of belonging and pride imparted by activism and 
membership of the movement has given many participants a 
profound sense of existential mission and meaning: it “creates 
and keeps my connection to life and gives me purpose” (Louise). 
Many participants discussed how being an advocate for the rights 
of people who use drugs has helped them to overcome “internal 
stigma and shame” (Jude) and to feel “at peace” (Miguel). This 
was especially the case for activists who discovered alternatives 
to abstinence and 12-step approaches through their involvement 
in the movement, since an abstinent philosophy has often rein-
forced the idea that social inclusion and acceptance is contin-
gent on being “clean” (Shaun), thus perpetuating self-stigma. 
For many activists, discovering the principles of harm reduction, 
has been an impediment to engaging with public and communi-
ty-services and has also created obstacles to finding employment 
and other opportunities which may help to “resolve” (Shaun) 
potentially more problematic aspects of drug use. Several par-
ticipants discussed criminalisation as a “tool of racism” (Andria) 
and an “imperialist, colonialist” policy (Zoe), the direct conse-
quences of which - police brutality, violence, extortion and arbi-
trary arrests – have disproportionately affected Black, Brown, 
indigenous and poorer people who use drugs due to “apart-
heid-style policing” (Shaun). Fundamentally, criminalisation is 
not “science-based” (Hollis), “makes no sense” (Jude), and the 
associated so-called War on Drugs was seen as “the single most 
catastrophic global public policy fiasco disaster” (Geoff), “a polit-
ical construct” which has cost countless lives. Participants spoke 
of ulterior motives driving the War on Drugs, for example as a 
“proxy” (Shaun) for repressive governments to achieve their 
political goals and retain a strong grip on power, or as economic 
fuel for a “1.5 trillion dollar… mass incarceration” industry in 
the US (Robert). 
 On a psychological level, drug prohibition and the criminal-
isation of people who use drugs has meant that the marginal-
isation, oppression and violence that many experience simply 
for using drugs “retraumatises” (Andria) people who may have 
initially arrived at drug use because of trauma and who continue 
to experience trauma. For example, a study in Indonesia found 
that nine in ten women who inject drugs had “faced violence by 
their intimate partner in the last year” (Putri). Criminalisation 
in turn has caused people who use drugs to internalise stigma, 
deepening a sense of self-blame and shame. As well as mental 
distress, the harms and risks associated with criminalisation 
have meant that many people who use drugs “hide in the shad-
ows” (Andria) and have not felt able to be open as someone who 
uses drugs, let alone as a more public-facing activist. 
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reduction have become overly sanitised, reduced to a schema of 
biomedical interventions to prevent HIV and blood borne virus 
transmission. One particular concern regarding HIV prevention 
funding underpinning the drug user rights movement has been 
the artificial separation of services for people who may inject 
drugs (the overwhelming focus of HIV prevention programmes) 
from those who do not inject drugs. More broadly, participants 
expressed concerns that harm reduction has become co-opted by 
a medicalised, pathologising approach that positions drug use as 
a “mental health disorder” (Edo), “brain disease” (Ernesto) or 
“soul sickness” (Brun) that in turn constructs people who use 
drugs as “sick, apologetic patients” (Mat). 
 Aware that HIV-related funding may impose a more narrow, 
technocratic agenda, many activists stressed the need to remain 
focused on community empowerment and “liberation” (Ann), and 
ending criminalisation and oppression of people who use drugs.
What have been the challenges  
in sustaining a resilient drug user  
rights movement? 
How criminalisation has constrained the movement
Some of the manifold challenges experienced by the drug user 
rights movement have been similar to those that may affect any 
social movement. For example, a classic model of social movements 
traces four stages that social movement typically pass through, 
of emergence, coalescence, bureaucratisation, and decline (which 
may be due to failures, co-optation, or such success that the pre-
viously marginalised movement becomes mainstream).3 However, 
the challenges the drug user rights movement has faced have been 
uniquely intensified by criminalisation and prohibition. 
and an empowering movement which stresses that problems are 
caused by the drug war and not by drug use itself, has provided a 
“very loving and very non-judgemental” (Louise) alternative. 
Links and tensions with the HIV movement
Participants also felt that the HIV/AIDS epidemic had been 
important in galvanising the drug user movement, which “dove-
tailed” (Jude) into funding for HIV and Hepatitis-C prevention 
for people who use drugs, through provision of harm reduction 
services such as sterile needles and syringes, and methadone 
provision. Indeed, from many participants’ perspective, fund-
ing for these services helped to encourage the emergence and 
coalescence of the drug user rights movement.2 HIV activist 
organisations of the 1980s, such as ACT-UP, inspired drug user 
rights activists, with many people who use drugs involved in the 
HIV response “suddenly realising they were agents of change” 
(Andria). The crisis of HIV created the urgency to spur on a drug-
user led movement, providing legitimacy as well as resources to 
a movement that in many parts of the world was “going against 
the local beliefs and belief system” (Jude). 
 Many activists explained the introduction and scale-up of 
harm reduction as a pragmatic decision by governments, to 
prevent transmission from people who use drugs to ‘the gen-
eral population’ and reduce costs to the health system, rather 
than driven by a genuine shift in values. While the spread of 
harm reduction services, especially in Western Europe, had been 
welcomed, many activists advocated for a broad view or “full 
spectrum” (Brun) of harm reduction, as a philosophy originally 
inspired by “anarchist ethics, which said that we have to chal-
lenge everything and that nothing should be assumed” (Shaun). 
Indeed, some participants were concerned that aspects of harm 
2. The “dovetailing” of the drug user rights movement on HIV funding can be 
considered an example of ‘resource mobilisation theory’ as discussed in the study 
of social movements. See McCarthy & Zald, 1977. Resource Mobilization and Social 
Movements: A Partial Theory. Available at: https://www.journals.uchicago.edu/doi/
abs/10.1086/226464
3. Christiansen, J. (2009). Four stages of social movements. Ebscohost Research 
Starters: Academic Topic Overviews. Available at:  https://www.ebscohost.com/up-
loads/imported/thisTopic-dbTopic-1248.pdf
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Representing the most marginalised people  
who use drugs
A key challenge that participants raised is ensuring that the drug 
user rights movement remains representative of the individuals 
most affected by criminalisation and marginalisation, as parts 
of the movement have evolved and become increasingly profes-
sionalised and bureaucratised. Participants generally stated that 
while most people ‘use drugs’ in some sense of the word (with 
alcohol, tobacco, coffee and even sugar used as examples of com-
monly used drugs), the movement needs to represent those who 
have experienced “suffering” (Bikas) because of their drug use or 
have “looked into the bowels of prohibition” (Jude). Many partic-
ipants recommended an inclusive, flexible “broad church” move-
ment “embracing our fluidity, our sense of community diversity, 
being welcoming of people who seek to be part of our community 
for their own reasons and on their own terms” (Charles). Indeed, 
there was a sense among certain participants that the movement 
needs to embrace and listen to anyone who wishes to make a con-
tribution, because of the high turnover: “We are losing people at 
a pretty insane rate. And we don’t have time or the ability to not 
listen to folks” (Louise). 
 A tension several participants raised is that often people who 
actively use drugs cannot openly represent their community, for 
example because of risks to their safety from being open about 
their drug use, so people who “used to use drugs… have the 
voice” (Simon). Thus it is vital for leading activists to remem-
ber that they are “representatives first” (Charles), and that the 
“voices of people who are using regularly - [that] become so mar-
ginal - need to be elevated” (Zoe) within the movement.
The complexities of working with funders
Participating activists underscored the challenge for a movement 
which has been continually beset by funding challenges. These 
challenges have not only included a lack of funding, but also a 
lack of control over existing funding that could allow groups of 
 Firstly, the movement has been fighting to safely and legally 
use drugs that are referred to by the Single Convention on 
Narcotic Drugs as “a serious evil”; this has posed a fundamental 
challenge for activists, repeatedly told that what they fight for 
poses a grave danger for individuals and societies. Criminalisation 
of people who use drugs has often complicated ‘coming out’ as an 
activist, and their ability to organise, assemble, and “collectiv-
ise” (Simon), to travel and meet other activists. As one activist 
stated, “The very thing that unites us puts us at risk” (Mat). 
Indeed, criminalisation and marginalisation has meant that 
many people who use drugs have ended up “in constant contact 
with the law” (Miguel), and have had limited access to housing 
and good health that could in turn enable greater involvement 
in more formal activism. The constant threat of arrest, and also 
preventable disease, overdose and death due to the “polluted” 
(Joergen) or “toxic” (Zoe) unregulated drug supply, thus con-
tinually risks immobilising activists and the movement losing 
momentum. Criminalisation creates huge time and money pres-
sure; life for people who use drugs is expensive and many live 
“really hectic” lives (Jude). 
 Thus the overwhelming impact of prohibition has meant that 
while the movement can celebrate significant successes, these 
represent a “bandaid on a severed artery” (Geoff) if the War on 
Drugs is continuing to wreak havoc further upstream. For exam-
ple, referring to Portugal where drug use (in small amounts) 
has been partially decriminalised,4 one activist merely described 
this as a tweak to the overall continuing “system of oppres-
sion” (Geoff). Criminalisation has “fuelled the user movement, 
because we have to fight for our human rights” (Joergen), but 
has introduced a huge host of challenges, above all because of the 
detention and deaths of so many leading activists.




the level of the community and sustain a pipeline of activists: 
“That’s how to be a resilient movement, by not making it about 
us. Making it about the next guy and the next guy and the next 
guy” (Nelson). The scarcity of funding has also often created 
friction or competition among networks of people who use 
drugs “when different donors have the same agenda, but they 
don’t communicate with each other” (Edo), emphasising the 
importance of funders streamlining their programmes. Many 
participants discussed the need for donors and funders to trust 
organisations led by people who use drugs more, feeling that 
their organisations have been subjected to disproportionate 
scrutiny. They felt that the input of people who use drugs has 
sometimes been “tokenised” (Ann) by funders, who have set 
the agenda rather than allowing the organisations to “define 
what we see as success” (Mat). Some participants also critiqued 
the one-size-fits-all approach of funders, imposing expectations 
and goals for programmes that may be inappropriate or ill-
suited to the context. 
Resisting co-optation and bureaucratisation
Difficulties in securing and retaining funding overlaps with 
another dilemma discussed by participating activists, namely 
how to balance ‘having a seat a table’ - a voice in high-level deci-
sion-making and policy implementation - with ensuring a focus 
remains on grassroots activism and responding to the needs of 
communities most directly affected by prohibition. 
 Some participants discussed the activist movement hav-
ing become overly professionalised, taking on a technocratic 
or bureaucratic character that may have facilitated attempts 
to work with actors “in the system” (Edo), but has sometimes 
problematically “shifted priorities” (Bikas) and presented a 
barrier to genuine representation of the majority of people who 
use drugs. Problems of co-optation were most often discussed 
in the context of global, UN-style activities; as one participant 
stated, “the biggest limitation to building strong drug user led 
people who use drugs to self-determine their activities and stra-
tegic direction. 
 There is a need for broader funding beyond harm reduction 
in the context of HIV prevention, which has provided much of 
the financial support, for example through the Global Fund (to 
Fight AIDS, Tuberculosis and Malaria). With absent, or uneven 
and unpredictable, support from domestic governments, many 
organisations led by people who use drugs have been reliant on 
funding for specific, defined services (such as needle and syringe 
programmes) rather than for broader advocacy activities aiming 
for systemic change. As one participant stated, “governments 
just… do the bits that they’re worried about, which is viral 
transmission or overdose” (Jude). Participants stressed the need 
for more core funding, for example from philanthropic funds, 
in order to stand up against prohibition and criminalisation, 
policies which themselves have made the rights of people who 
use drugs a “hard sell” (Geoff) compared to other social justice 
issues. The limited funding means there has been little time or 
resource for anything other than ‘firefighting’ the widespread, 
immediate harms caused by prohibition, rather than organising 
more strategically to fight prohibition itself. Without the gov-
ernment tackling the root causes and effects of the criminalisa-
tion and marginalisation of people who use drugs, activists have 
ended up in “a reactive position… fighting for people’s lives” 
(Zoe). There is also the more practical implication that a lack 
of core funding has made it challenging to run and administer 
organisations, for example “keeping an office going” (Simon), 
and hiring and training paid staff who could sustain the move-
ment; as one participant stated, “You need to invest in us if you 
expect big things from us” (David). 
 Several participants highlighted the unpredictability, incon-
sistency and incoherence of funding as a common experience, 
for instance with drug user rights organisations rapidly going 
from being funders’ “flavour of the year” (Hollis) to having 
to shut down. Where there is funding, it must filter down to 
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becoming capacitated. That doesn’t mean you need to be pat-
ronising or directive.” (Shaun). Such capacity building could 
range from improving technical skills to manage an organisa-
tion, such as managing budgets, to “learning the language of 
diplomacy” (Jude). While funding is necessary for such activi-
ties, participants also stressed the importance of mentorship in 
order to sustain and upskill a pipeline of activists and advocates, 
knowing that “our generation will come and our generation will 
go” (Charanjit). 
 Specific training and support is also needed to alleviate the 
psychological and emotional distress that many drug user rights 
advocates have experienced. There are particularly high levels 
of “burnout” (Judy) in the movement of people who use drugs, 
with many activists dealing with health problems, complex 
employment, living or family situations, and grief and loss after 
witnessing the preventable deaths of friends and colleagues in 
their movement and community. Other activists’ deaths can lead 
to a sense of “inertia”, of “hitting your head on a brick wall” 
(Jude) in the campaign against prohibition and can cause the 
momentum to evaporate. As one participant stated, “When we 
lost our leaders, part of the community lost their enthusiasm to 
fight for the rights of drug users and to continue the struggle” 
(Putri). The scale of bereavement and grief can make the slow 
pace of change even more frustrating, and activists require sup-
port to cope with the “heaviness” (Angela) of being an activist, 
and with the alienation and stigmatisation which has affected 
and continues to affect so many people who use drugs. Indeed, 
one participant recommended formal psychological support for 
activists, “supervision in terms of psychological counselling… 
that should be paid for by the grant givers and by the organ-
isations” (Shaun). Participants also spoke of the importance 
of imbuing the movement’s activities with fun and a sense of 
humour wherever possible, despite the seriousness of the mis-
sion: as one stated, “We need to laugh more” (Theo) and another 
that “it has to be enjoyable, the work” (Anya). 
movements is people not willing to share the power that they get 
that comes along with getting on that UN gravy train, and then 
you don’t want to get off” (Hollis). Indeed, there was awareness 
that organisations too concerned with influencing at higher lev-
els of policymaking may have become less resilient and prepared 
to tackle emergencies at the community-level, such as the over-
dose crises in Canada and the US. 
 As the movement has become more professionalised, increas-
ingly represented at high-level conferences and forums, partic-
ipants recommended keeping a focus on informal activities to 
keep movement “lively” and “developing” (Anton). In the view 
of many participants, organisations and projects require support 
to develop “organically” (Anya), rather than being moulded into 
overly corporate structures which can create “organisational tox-
icity” (Anya) and create “complex institutional set-ups” (David). 
Indeed, while some level of bureaucratisation and structure has 
been beneficial, it is important to avoid imposition of values on 
organisations led by people who use drugs, and to allow mem-
bers’ creativity and momentum to underpin organisations’ direc-
tion, even if that means the group “morphs into” or “cleaves off” 
(Ann) into something different and unforeseen.
Training and supporting activists to remain resilient
An additional challenge associated with professionalisation is 
that while the insights, expertise and lived experience of people 
who use drugs must underpin drug policy and science, people 
who use drugs may also want or need to learn new formal skills 
to further their activist work within the movement. 
 Especially at the regional or global level, activists for drug 
user rights have needed to become “fluent” (David) working 
with a complex assemblage of UN agencies, scientific organisa-
tions and NGOs. Discrimination and marginalisation has meant 
that many people who use drugs have not “gained access to edu-
cation… And so this is a population that you can’t just dump 
a lot of money on. You need to help them and assist them in 
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Some activists commented on “a feeling that we’re fighting 
between each other, instead of sitting together and saying, 
‘Okay, how can we use this as a complex, overall strategy for 
everyone’” (Anya). 
 In terms of more individual-level conflict, participants 
referred to the “infighting” and “lateral violence” (Jude) which 
has existed in parts of the movement, a phenomenon whereby 
marginalised and oppressed groups direct anger inward and 
onto their peers.5 Nonetheless, the emphasis of participants was 
often on the need to “meet people where they are… and just 
keep working on it” (Ann), calling out unacceptable behaviour 
or prejudice but ultimately “trying to build people up, because 
we need strong people to work together” (Jude). As one partici-
pant stated, if there is conflict within or between organisations, 
a restorative approach has often proved more effective than rep-
licating “practices of the criminal justice system where we exile 
people or we go after people” (Zoe). 
 Overall, activists were aware of the real risks of being 
“divided and conquered” (Ernesto), and emphasised the 
importance of maintaining unity and building trust when 
circumstances may militate against this. As one example, 
developing organisations’ policies and rules collaboratively, 
working out the details of funding, budgets and governance 
arrangements, has built trust among members, so that they 
“complete each other” rather than “compete with each other” 
(Edo). Furthermore, keeping everyone’s focus on the long-
term goal of decriminalisation can help to “amalgamate” 
the movement and prevent “splintering” (Simon). Above all 
participants highlighted the need for organisations and the 
broader movement to remain a safe, welcoming space, where 
“you can be open and be yourself and live your life in a full and 
expressive way” (Annie).
Overcoming inter-personal and inter-organisational 
differences
A final area of challenges for a resilient movement discussed by 
the participants relates to how activists for the rights of people 
who use drugs resolve conflicts and differences. 
 One very practical issue concerns the language of the move-
ment. With most global discussions and advocacy activities con-
ducted in English, non-English speaking activists “resent not 
being able to participate” and to access the relevant informa-
tion (Brun). Dedicated funding is required for “translation, for 
people to hear it in their own language in the same moment” 
(Ernesto). At country level, one language still tends to dominate 
which complicates communication between different groups of 
activists, and often the most marginalised people who use drugs 
may speak a language other than that spoken by the principal 
activist groups. At a more conceptual level, different societies 
and cultures may have varying discourses for talking about 
drug use, which makes interpersonal and inter-organisational 
dialogue and understanding so important. As one participant 
stated, “context is everything” (Ann); for example, a faith-based 
organisation with “sober” in the name may seem to signal an 
abstinence-based approach although it may in fact be largely 
composed of people who actively use drugs. Indeed, building the 
movement internationally “really requires people to see and 
connect with each other across culture, across international 
boundaries, across languages, and to see our common humanity 
as drug users” (Mat).
 This relates to a broader challenge, about maintaining 
trust between people who use drugs and networks who are in 
such different situations, often facing hugely varying circum-
stances but brought together in response to the same urgent 
crisis of prohibition. The scarcity of funding has created huge 
tensions between organisations, and especially when drug 
user rights groups are institutionalising more formally, “what 
I’ve seen historically is people just eat each other up” (Zoe). 
5. Clarke, Y., Augoustinos, M., & Maline, M. Lateral violence within the Aboriginal 
community in Adeladie: “It affects our identity and wellbeing’. Available at: http://
manage.journalindigenouswellbeing.com/index.php/joiw/article/view/35
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peers, replacing previous feelings of disconnection, shame and 
self-stigma. Some participants also mentioned the increasing 
humanisation of people who use drugs as a success, as the start 
of the long journey towards winning over the hearts and minds 
of the general population, since “politicians don’t move unless 
the general population moves. They’re reliant on votes and they 
will do whatever the vote is saying” (Shaun). Indeed, there have 
been some subtle but meaningful changes in how policymak-
ers, legislators and scientists talk about drug use, thanks to the 
involvement of people who use drugs in policymaking, for exam-
ple changing wording of South Africa’s National Drug Master 
Plan from “a drug free South Africa, to a South Africa free of 
drug abuse” (Shaun). This notion of people who use drugs telling 
their stories, to show “there are real faces behind some prob-
lems that may seem abstract to decision makers” (Anya) was a 
common thread throughout participants’ accounts, recognising 
that personal stories have the power to “disrupt the narrative” 
(Shaun) and taken-for-granted views on drug use.  
An adaptive mix of strategies
While participants naturally held different views about how 
change could best be achieved, there was a general consensus 
regarding the need for a “mix of strategies” (Anya) underpinned 
by a flexible, adaptive approach and always meaningfully involv-
ing people who use drugs. For example, sometimes protest, civil 
disobedience or radical action may be appropriate, while at other 
times or simultaneously, strategic litigation or negotiation may 
be a route to change. The relative balance of these strategies 
has necessarily varied according to context; as one participant 
concluded, “The strategies the movement has used over the dec-
ades to try and achieve their aims have been suited to the times” 
(Jude). A good example was the action undertaken to influence 
the Commission for Narcotic Drugs (CND); INPUD members and 
other NGOs organised protests featuring activists in cages outside 
the CND entrance, to draw attention to the unjust incarceration 
How do activists  
effect the process of change?
In the face of such challenges, it is important to celebrate the 
participation of drug user rights activists in the processes of cre-
ating change at the local, national, regional and international 
levels, especially given that criminalisation and stigma can lead 
to an “invisibilisation” (Ernesto) or “anonymisation” (Tonny) of 
people who use drugs that often erases and excludes them from 
public policy. Many participants stated that even the fact that 
organisations and movements led by people who use drugs exist 
and have survived is itself a success; the movement’s “existence 
until 2019 is itself an achievement” (Bikas). The fact that some 
people who use drugs are moving “from the streets to the tables” 
(Happy) and having a voice in policymaking and agenda-setting, 
is a considerable achievement to celebrate. 
 The spread of needle exchanges, access to harm reduction, 
availability of opioid substitution therapy and naloxone in cer-
tain countries, and drug consumption rooms in certain Western 
European countries and Canada, were all cited by activists as 
concrete, hard-won successes. Often with little support, organ-
isations led by people who use drugs had mobilised from the 
bottom-up to build an evidence base for enhanced policies and 
interventions, such as in New Zealand where activists worked 
to “build up a body of evidence around, getting the government 
to understand that, they needed to change that law” (Charles). 
There was a sense of pride from certain participants that their 
countries had played a pioneering role within their region, for 
example in Tanzania as “the first Eastern African country to 
implement very good harm reduction programs like needle and 
syringe programmes, a methadone programme, and also the 
engagement and involvement of people who use drugs” (Happy).
 Although less tangible, a significant and fundamental suc-
cess of the movement for many activists was the feeling of 
purpose, belonging and meaning it has given them and their 
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(Shaun), provided they do not impose their values and encroach 
on the drug user rights organisation’s freedom to operate and 
set the agenda. While allies and partnerships were often desira-
ble, many larger organisations – even if working towards similar 
goals to the movement of people who use drugs – may be “very 
reluctant to step into this area… It is difficult to get people to 
partner with us, to try and end prohibition” (Geoff).
 At times however, strategic alliances may involve more stealth 
and ingenuity, working to benefit from opportunities afforded by 
partnership with organisations who may have very different end 
goals. As one participant stated, about the experience of working 
with a more recovery-oriented organisation to gain access to a 
meeting space, “If I said we’re starting a user’s union, we’re really 
militant and we’re trying to get drugs legalised, they’d just go 
‘Fuck off’” (Ann). In some contexts though, where partners have 
sought to enforce their values and agenda in a directive manner, 
the best response has sometimes been to ‘go it alone’; for instance, 
“when local policy makers were so busy talking about recovery 
that they wouldn’t engage with harm reduction, we just withdrew 
from the policy forums and focused on helping our peers” (Mat). 
 Joining with other “like-minded” (Simon) activist groups, and 
“being rooted in other people’s movements” (Zoe), such as move-
ments fighting poverty, decriminalisation of sex work, and for 
racial justice, gender and LGBTQ equality, were also seen as inte-
gral to the liberation of people who use drugs from criminalising, 
oppressive systems. In one participant’s words, “Intersectionality 
is what makes every movement strong”, and it is important to 
recognise that “there’s huge risks and huge challenges for some 
people more than others”, for example women who use drugs 
being at particular risk of sexual violence.6 Participants thus saw 
allying with complementary social movements as crucial for an 
urgent “fight [that] will take all of us” (Louise). 
of people who use drugs and the “literally and figuratively impris-
oning” (Judy) nature of drug policies. At the same time, activists 
worked progressively to build capacity of members to engage with 
and better understand the complex processes of the CND, and 
INPUD now has credibility even within this conservative body. 
 Indeed, most participants underlined the importance of build-
ing diverse coalitions incorporating a variety of skills in order 
to push for change on different fronts, including campaigning, 
advocacy, scientific and research skills, and knowledge of politi-
cal, legal and financial systems. Some members may feel better 
equipped to organise protests, others to lobby, others to work 
with government, and others to speak to the media. As one par-
ticipant stated, “Success happens when different coalitions come 
together” (Zoe). Fundamentally, people who use drugs must be 
the ones to lead, define the strategy, and leverage their talents, 
bearing in mind that “drug users are innovators. We constantly 
have to adapt and change to the changing drugs, changing 
risk, changing environments, changing policing attacks on our 
community, and we show such creativity in that world” (Mat). 
While innovating, it is also important for different networks in 
the movement to share knowledge, to promote strategies that 
are effective and thus avoid “reinventing the wheel” (Nelson). 
Participants agreed that the movement needs pluralism, a diver-
sity of ideas, strategies and passions, and ultimately to combine 
these “under one umbrella” (Simon) in order to speak with “a 
unified voice” (Charles) to bureaucrats, scientists and politicians 
external to the movement.
Building partnership around common causes
Participants spoke of working with actors external to the move-
ment as a crucial but challenging element of effecting the change 
process. Partnership and collaboration between groups and net-
works led by people who use drugs with more established organ-
isations – for example those working in HIV - can provide more 
credibility, and greater “levels of governance and reputation” 
6. INPUD (2014). Drug User Peace Initiative: A war on women who use drugs. 
Available at:  https://www.unodc.org/documents/ungass2016/Contributions/Civil/
INPUD/DUPI-A_War_on_Women_who_Use_Drugs-Web.pdf
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when you’re at the table, there’s all sorts of ways and tactics and 
strategies that are used that stigmatise you and diminish your 
voice” (Annie). There is always the risk that representation from 
people who use drugs in these more high-level policymaking fora 
becomes “clientised and tokenised” (Ann), to ‘tick a box’ rather 
than to invite authentic engagement.
 As such, there was a clear message from participants that 
dialogue, diplomacy and negotiation with governments and 
policymakers must be balanced and coordinated with more 
radical strategies in order to drive progress. As one partici-
pant expressed, activists have to be “open for dialogue, while 
being radical on the ground… [and] have a dialogue in debate” 
(Tonny). While working with powerful actors in the main-
stream establishment can be a force for change, it can come 
with risks even beyond being co-opted and neutralised. Indeed, 
one participant discussed working with the pharmaceutical 
industry as a “tricky thing”, providing the organisation with 
funding but with the additional motive that “they want to go 
through the back door to our network and to set off some argu-
ments or other things or for their medication over a way of 
treatment… we have to be clear on the way we handle this”. 
In many contexts, especially where authorities are highly pro-
hibitive and repressive, it may be impossible to fully resolve 
the discontinuities between more grassroots-level action and 
working with more established bodies, since “you start sitting 
at the table, and suddenly you can’t be as radical about the 
things you want to say. You start trying to push things incre-
mentally, and sometimes that works and a lot of times it doesn’t 
work” (Zoe). Indeed, there was a sense from some participants 
that the involvement of drug user advocates at high-level meet-
ings of drug policy, bureaucracy and research, and the everyday 
worlds of people who use drugs themselves, are somewhat irrec-
oncilable, and the different modes of engagement across drug 
user networks should be considered as “two different kinds of 
drug user groups” (Ann). Therefore, although a challenge to 
 While allies are vital, participants were clear that people who 
use drugs must have the ultimate say in decision making, since 
allies “will do the work but won’t wear the hair-shirt” (Jude). 
An illustrative example of this insight, discussed by several par-
ticipants, was progress made in decriminalisation or legalisation 
of cannabis; while considered a positive development, many felt 
that the systemic impact of this change had been limited, in part 
because the market has been co-opted by large businesses, and 
that fewer people being arrested for cannabis possession simply 
meant more arrests for people using other drugs. As one par-
ticipant stated, “The people that they want in jail, they’re still 
incarcerated. They just found another way to do it” (Jude), thus 
showing how incremental progress towards decriminalisation/
legalisation of some drugs, whilst not others, may have created 
new inequalities and fault lines within the movement of people 
who use drugs.
Working within and outside the system
While participants on the whole suggested that a plurality and 
diversity of strategies was required to effect change, there were 
subtle differences of opinion in terms of how closely to work with 
established policymaking, legal, social and scientific systems that 
may constrain and co-opt as much as they enable change. Some 
activists suggested that being in the room and having a presence 
where decisions are made is a crucially important first step; you 
“don’t have to say anything. You just have to be there” (Jude), 
and this may be a first step to sensitising those in power to issues 
people who use drugs face. Presence ‘in the room’ or ‘at the table’ 
may encourage use of more humanising and less stigmatising ter-
minology, for example shifting a high-level committee away from 
stating that Hepatitis C is transmitted through injecting drug 
use to “transmitted through sharing contaminated equipment” 
(Jude). At the same time, it is vital that the presence of people 
who use drugs ‘at the table’ is meaningfully valued, as there is 
the possibility that “people… say they want you at the table, but 
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example, where people who use drugs were involved and con-
sulted to develop what has now been adopted as normative guid-
ance by the Global Fund. By conducting training sessions with 
community-based advocates, “we’ve seen [IDUIT] lead to… real 
substantial changes, I think, at the national level… having com-
munity advocates using it to advocate on harm reduction policy in 
their country, and seeing some wins like the inclusion of buprenor-
phine” (Judy). Often the progress made can only be recognised 
with hindsight: “When you’re in it, you don’t necessarily believe 
you’re getting anywhere… But when you look back, in retrospect, 
a lot has changed in just a few years” (Angela). Indeed, the mes-
sage from many activists was that meaningful change, especially if 
enacted through official channels, has taken huge amounts of time 
to achieve. One activist recounted how searching for funding and 
an institution to implement a naloxone programme in Denmark 
“altogether took nine years” (Joergen) since an initial discussion 
between activists and doctors. 
 Therefore, mobilisation by activists working at the high-
er-level can help to secure gains for people who use drugs 
working on the front line. It may particularly be the case for 
countries where the government is extremely oppressive and 
prohibitive that working strategically at the regional or global 
level is the only way to maintain pressure for change. For exam-
ple, a case has been ongoing for several years in the European 
Court of Human Rights, brought by Russian activists against 
the Russian government after being denied access to methadone 
and buprenorphine.8 While the court ruled in the Russian gov-
ernment’s favour, “participation in this process has… empow-
ered people and inspire more people to actively fight for their 
human rights” (Anya). Some activists, even in oppressive con-
texts where positive changes have been limited or even reversed, 
discussed being encouraged by some tentative worldwide trends 
towards decriminalisation, instilling them with an optimistic 
achieve given the inevitable trade-offs between being more rad-
ical and dissident versus working ‘within the system’, it is vital 
that activists working within the system continue to elevate 
the most marginalised voices and networks, who may have no 
access to government funding or official recognition. 
 Being willing to change strategy and adapt to any opportuni-
ties the system offers was seen as a means to precipitate mean-
ingful change in the eyes of certain participants. One activist 
in Indonesia described how their organisation previously had no 
links to the government whatsoever, and would critique the gov-
ernment but without eliciting any reaction: “We were just hit-
ting ourselves against a brick wall… then we started to change 
our strategy, and so we started to get acknowledgment from the 
government, to get them to know us…, hear us and put us as 
an equal partner” (Edo). At the same time, this participant sug-
gested the need to have “one foot half in the system, and one half 
outside the system” in order to “play the game” of changing pol-
icies and perceptions, and ensuring developments at the policy 
level are communicated effectively back to the grassroots level of 
the people who use drugs whom activists represent. 
 Much of the challenge stems from the slowness with which 
more systemic and abstracted change happens, in sharp contrast 
to the urgency of the crises many people who use drugs and their 
communities are facing on the front line around the world. It can 
feel like working with bodies deeply embedded within a prohibi-
tive system like the CND represents “tinkering with a system, you 
know, and you’re looking at small changes” (Judy). However, with 
the appropriate follow-up outside the system and on the ground, 
high-level actions can lead to tangible progress at the local level. 
The development of the IDUIT (Implementing Comprehensive 
HIV and HCV Programs with People who Inject Drugs: Practical 
Guidance for Collaborative Interventions) guidelines7 is one good 
7. INPUD (2017). Implementing Comprehensive HIV and HCV Programmes 
with People Who Inject Drugs. Available at: https://www.inpud.net/en/
iduit-brief-guide-people-who-use-drugs
8. V. Junod & O. Simon. (2020). Abdyusheva and Others v. Russia: a Sadly Missed 
Opportunity. https://archive-ouverte.unige.ch/unige:131253/ATTACHMENT01
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the ability to put lessons learnt into practice depends on a range 
of political, legal, socio-economic, cultural and structural factors.
The resilience of activists in the face  
of extreme oppression
Although sharing many perspectives and examples of successes, 
activists’ geopolitical context clearly emerged as the most sig-
nificant determinant of possibilities for empowerment, advocacy 
and change. 
 Activists working in South and South-East Asia for example 
spoke of the conservative laws and policies that have silenced 
and repressed drug-user led activism, which “make it very dif-
ficult to be very vocal and get ourselves recognised as a legal 
entity” (Anand). They drew attention not only to the widespread 
compulsory drug detention centres in many South-East Asian 
countries, but also private rehabilitation centres, where many 
coercive practices and human rights violations have taken place. 
Activists based in this region saw clear evidence of ‘copycat pol-
itics’, with extrajudicial killings of people who use drugs in the 
Philippines catalysing authoritarian, repressive policies in other 
Asian countries, such as Sri Lanka’s reintroduction of the death 
penalty for drug offenses.9 This climate has made it extremely 
challenging to engage with those in power, who oppose any 
notion that “drug users can be part of the change” (Raheem) 
and whose policies often contravene both scientific evidence 
and human rights principles. In countries like Afghanistan, the 
criminalisation and ostracisation of people who use drugs has 
prevented any harm reduction initiatives from getting off the 
ground. In one participant’s words, “criminalisation does not 
allow us to help our community. Our organisation does not have 
a sufficient budget to deal with harm reduction in Afghanistan” 
(Raheem). In the absence of government support, international 
sense that progress towards ending prohibition is “just a matter 
of time” (David). 
 Yet for many, the political stasis on drug policy reform in most 
countries and globally has meant that many activists have had to 
bypass the official avenues in order to undertake the changes that 
are desperately needed at the local or neighbourhood level. As one 
activist stated, “We can’t wait for the slow tick-tock of politics 
anymore” (Robert). Indeed, participating activists related how 
they had, for example, set up illegal drug consumption sites in the 
face of government inaction in Canada, or “brought in Naloxone 
illegally and distributed it amongst people who use drugs so that 
they wouldn’t die” (Zoe). While these activists spoke elsewhere 
of the importance of advocacy within official high-level spheres, 
their direct actions to bring about change demonstrate the impor-
tance of “local solutions to local problems” (Simon). Indeed, in 
countries like Canada, what began as an illegal project of a drug 
injection site changed laws and policies around opening sites and 
around overdose response “overnight” (Zoe). This is a good exam-
ple of “taking power back” (Robert): “It’s time we no longer allow 
ourselves to be invited to others’ table. It’s time we started invit-
ing them to our table, right?”
The importance of context as an enabler  
or barrier to successful activism 
As the preceding sections on progress and challenges faced by 
the drug user rights movement show, there are significant ten-
sions, dilemmas, complexities and differences of opinion in terms 
of what the movement stands for and the ways that meaningful 
change can be achieved. Inevitably, such a brief report seeks to find 
commonalities and unifying threads in participants’ narratives in 
order to tell a coherent story of the movement. However, this sec-
tion seeks to focus specifically on differences across the contexts 
and populations of people who use drugs, and to demonstrate how 
9. Human Rights Watch (2019). Sri Lanka: Resuming Death Penalty a Major 
Setback. Available at: 
https://www.hrw.org/news/2019/06/30/sri-lanka-resuming-death-penalty-major-setback
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done before. And, we were lucky we could just run with it… 
A lot has happened and, we have a long way to go still. But 
we’re moving” (Nelson). This demonstrates the importance of 
international sharing of lessons within the movement for peo-
ple who use drugs, while remaining mindful of how context 
inevitably shapes what is achievable. 
 In Eastern Europe and Central Asia, activists discussed how 
the political climate has not only repressed people who use drugs 
themselves but also civil society activism more broadly. As an 
activist in Russia commented, “the obvious problem is that the 
country is run by a dictatorship, so it’s not much that the civil 
society movement do, but they are doing their best” (Anya). In 
this context, not only are people who use drugs and practices like 
harm reduction criminalised, but also activism by people who 
use drugs; in Russia, “people are being arrested just for protest-
ing for the rights of people who use drugs” (David). 
 Despite such overwhelming top-down pressures, activists in 
these contexts were clearly not deterred and saw such oppres-
sion as a spur for political resistance. Additionally, some held 
out hope of getting through to governments: “We need to remain 
engaged with key stakeholders, UN agencies, and the extent 
possible with the government. I know it’s very challenging. It’s 
easier said than done, but then we still need to ensure that we 
are there to show the human face of who we are, you know, and 
how we contribute to the community and our society” (Anand). 
Activists based in relatively more liberal countries frequently 
expressed their solidarity with and admiration for activists 
based in countries experiencing particularly acute oppression, 
such as the Philippines, Russia, and the US; as one participant 
stated, “those people who are just being traumatised and bru-
talised beyond belief, and they’re still standing up fighting… I 
think that’s mighty and I’m really proud of them all” (Jude). 
Indeed, several participants mentioned the importance of cel-
ebrating and amplifying the work being undertaken in much 
more oppressive and lower-resource settings, where “drug user 
NGOs such as Médecins du Monde have stepped in to provide 
methadone treatment. 
 This is similarly the case in certain African countries, 
where new activist leaders and organisations have emerged 
relatively recently. In the absence of government support in 
countries like Tanzania, Médecins du Monde has established a 
centre providing harm reduction services, such as sterile nee-
dles and syringes, alongside antiretrovirals. People who use 
drugs continue to face huge challenges, being both criminal-
ised and pathologised, and yet by engaging with the govern-
ment and working through bodies like the Tanzania Country 
Coordinating Mechanism for the Global Fund, “we are at least 
being heard… and listened to” (Happy). There have also been 
particular challenges in South Africa, where funding for peo-
ple who use drugs has been very closely tied to the HIV/AIDS 
movement, in the country with the highest number of people 
in the world who are living with HIV. One participant referred 
to a schism opening up between people who use drugs and the 
HIV movement, seeing “the move of HIV activists to deny the 
rights of people who use drugs. I’m seeing an attempt to dis-
tance the HIV movement from the people who use drugs move-
ment… As HIV funding decreases, so funding for drug user 
movements decreases, but the two are inextricably linked” 
(Shaun). Indeed, activists here highlighted how many of the 
tangible successes for people who use drugs in South Africa 
have been achieved through leveraging HIV prevention fund-
ing. Although there has been progress in engaging with the 
government, “very little funding or support for this movement 
comes from South African soil. Most of it comes from interna-
tional funding” (Angela). While the relatively new status of the 
movement in South Africa has presented challenges, one par-
ticipant felt that the speed of progress owed much to learning 
from activists in other parts of the world: “I think we are lucky. 
We got to learn from a lot of other countries… I think the best 
thing is that we didn’t have to invent anything, it’s all been 
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are not automatically supportive of drug user rights, as they may 
see “drug use as part of the capitalist movement” (Ernesto). In 
addition to differing mindsets around drug use, there are prac-
tical challenges for activists based in large cities seeking to rep-
resent rural indigenous communities, since the lack of funding 
and organisational infrastructure for activism led by people who 
use drugs has made it very difficult to “synchronise and align” 
(Brun).
Persistent discrimination and inequalities in more per-
missive contexts
In contrast, activists from more inclusive welfare states such as 
Norway, Denmark, Germany and the Netherlands, more removed 
from the crises of the global drug war, naturally felt more 
included in decision-making on drug policy. In countries like the 
Netherlands, partial decriminalisation has contributed to a more 
“relaxing situation” for people who use drugs, meaning “we don’t 
need to hide ourselves that much” (Theo). At the same time, “we 
are not looking out for other people anymore, and that’s a neg-
ative part of it” (Theo), implying that as people who use drugs 
have become more integrated into the mainstream, the drug 
user rights activist community may have become less strong and 
defined. Even in a country like Norway, described as “pragmatic, 
diplomatic and cooperative” (Arild), changes can feel slow, polit-
ical opposition remains to initiatives such as drug consumption 
sites, and many people who use drugs are marginalised, in poor 
health, and subjected to police harassment and criminalisation.
 Indeed, many of the activists in relatively more permissive 
societies spoke of some of the paradoxes and discontinuities in 
terms of how people who use drugs are considered and treated as 
citizens. For example, in Vancouver, Canada, there has been sig-
nificant progress in changing hearts and minds, and establishing 
safe drug consumption sites. For example, harm reduction poli-
cies are now considered ‘vote-winners’: “you cannot win a civic 
election … if you’re going to come in and shut down all the, harm 
movements work, and they are alive, and they doing a wonderful 
job under very bad conditions” (Dirk).
Effects of the War on Drugs on activism in Latin America
The situation in these countries may be compared and contrasted 
with the Latin American region, where the extreme violence of 
the global ‘War on Drugs’ has dominated domestic and regional 
policies and discourses around drug use. Activists advocating for 
drug user rights are often stereotyped as being “drug traffick-
ers” (Ernesto), and people who use drugs have become “guilty 
by association” because of the “big cloud” (Brun) of the War on 
Drugs. As much of the drug use across the region is non-injecting 
drug use, and rates of HIV among people who use drugs commu-
nities have been low, activists related that the region has his-
torically “been left out of most of the harm reduction initiatives 
and grants, and … the Global Fund processes” (Ernesto). This 
has made it more challenging to formalise activist networks led 
by people who use drugs, with the Latin American Network of 
People who Use Drugs starting up relatively recently, in 2011. 
With limited resources, it has been challenging to organise not 
only at the regional level but even nationally. The two partici-
pating activists from Latin America drew attention to the use of 
drugs among the continent’s indigenous groups. For example, in 
Mexico, drug use as an element of “traditional plant medicine” 
(Brun) is well-documented and established. However, drug use 
has since taken on a “very decadent and obscure aspect” and, 
amid the violence of the drug war, become symbolically associ-
ated with the “sin” and “deviance” (Brun) of modern, Western 
culture and dissociated from traditional drug use. As such, it is 
challenging to build diverse coalitions of people who use drugs, 
for example bridging between users of traditional psychedelics 
like peyote and “street drugs” such as cocaine and heroin. This 
means that while left-wing governments, such as Uruguay, have 
made moves towards legalisation of cannabis and harm reduction, 
the politics of drug use are complex and left-wing governments 
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Noise, they lost it” (David) and momentum for drug policy reform 
came to a halt. Given the upheaval that political changes and 
reversals can wreak for movements led by people who use drugs, 
participants suggested it is important to work strategically where 
possible to ensure continuity. For example, one activist suggested 
“We need standard operating procedures that will stay there to 
lead the law so that any leader who comes after… can also follow 
what the other one has implemented” (Happy). 
Learning from past generations, 
inspiring future generations 
A final theme which featured strongly across all participants’ 
accounts, and which cuts across the previous themes, was 
the importance of activists telling their stories, sharing their 
insights, and inspiring and training other people who use drugs 
to become involved in and lead their movements. 
 Upskilling and training activists is important not only for 
understanding how the relevant governmental, legal, health-
care and research systems work but also for instilling newer 
advocates with a sense of confidence and self-belief. As one 
participant stated, “By getting the training, people improve 
their confidence, and then they feel… yeah, I can be an agent 
of change” (Andria). As another participant commented, “You 
have to be willing to bring other people up in this movement... 
You’ve got to be transparent and share that information and 
teach” (Hollis); this could be, for example, by bringing younger 
or newer advocates along to high-level meetings with donors 
in order to share and pass on knowledge and experience. Many 
experienced advocates wanted to provide a newer generation 
with the kind of support and advice from which they them-
selves had benefitted earlier in their career: “A lot of younger 
advocates come with great new ideas and from different back-
grounds, and we owe it to them, just like how my mentors took 
reduction and the injection sites in Vancouver” (Ann). However, 
access is lacking in terms of “access to toilets and… housing. It’s 
just bizarre that… those are so hard to get. They’re much harder 
to get than an injection site” (Ann); in these contexts, seemingly 
more controversial initiatives have been easier to advocate for 
and achieve than comprehensive access to basic services for peo-
ple who use drugs. Furthermore, reduced and more select crimi-
nalisation in more liberal contexts such as Canada and Australia 
may further intensify disparities in the disproportionate incar-
ceration of certain groups, such as indigenous and Black people 
who use drugs. 
Political turmoil and its implications for 
drug user rights activism
Despite these huge discrepancies in the experiences of drug user 
rights activists across and within geographies and contexts, there 
was an awareness that change can come very suddenly, and nei-
ther increasingly progressive nor regressive policies are a given 
when drug policies can shift so rapidly in response to a political 
transition. One example provided by participants of policies mov-
ing in the wrong direction was the ban on opioid substitution ther-
apy in parts of Ukraine after annexation by Russia. At a more 
local level, activists can find they are working effectively in col-
laboration with policymakers, only to suddenly find themselves 
“thrown under the bus” (Nelson) in order for politicians to make 
a statement, since “unfortunately in politics they play with what’s 
popular, not with what’s correct” (Nelson). Participants had also 
experienced instances where policymakers and authorities had 
promised to deliver on activists’ demands for change, and the 
activists had consequently de-escalated their protests and organ-
ising, only to find that no policy changes materialised. One activist 
associated with Georgia’s White Noise movement had experienced 
this, with the result that “many people who had trusted White 
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Key successes of the movement
• In the Netherlands, activists convinced government ministers to 
fund a harm reduction service led by people who use drugs starting 
from the late 1970s, and then solidifying in the 1980s in response to 
HIV/AIDS. “We were firstly only focusing on harm reduction on HIV 
prevention… and then we found out it’s better to have a broader 
view on the project, and to fight for the interest of users” (Theo).
• Activists representing people who use drugs, including Marsha 
Burnett and Omayra Morales, came together to address the 1998 
UN General Assembly Special Session on ‘the World Drug Prob-
lem’: “they gave these really fantastic dynamic speeches, saying, 
‘This is how your policies are actually affecting our lives’” (Andria).
• In Vancouver, Canada, activists led the founding of Insite, the first 
government-sanctioned supervised injection site, in 2003. This 
built on more informal supervised injection sites activists had es-
tablished in the 1990s. “We had illegal sites before that, but having 
the government pay for it was a big deal. There’s other downsides 
to it - they wouldn’t open another one for over 10 years…” (Ann), 
meaning that organisations such as VANDU have continued to run 
informal, non-government-sanctioned supervised injection sites 
in Vancouver. Later, in 2017, in Moss Park, Toronto, activists set up 
an unsanctioned supervised drug consumption site based out of 
a tent and trailer in response to soaring overdose deaths. In the 
face of inaction from authorities, “we went ahead and opened one 
ourselves” (Zoe).
•  In the UK, activists who use drugs worked with primary care doc-
tors to establish concrete guidelines for working in primary care 
with people who use cocaine and crack, published in 2004. “The 
GPs [primary care doctors] were able to lose their stigma and 
discrimination against us as crack users, because they started to 
work with us and understand us” (Mat).
• After fifteen years of negotiations between activists and govern-
ment in Denmark, the Prime Minister announced in 2007 that her-
oin treatment would be introduced, and since 2010 people have 
access to heroin on prescription. The government said that the 
programme would be “permanent, and not a trial – because you 
can’t give users heroin and take it away again” (Joergen).
• Working with the government’s National AIDS Control Organisa-
tion, activists helped develop the first standard operating proce-
dures for implementing buprenorphine among people who use 
injecting drugs in India in 2008. “The activist community has been 
very active and very, very strong when it comes to coming together 
and advocating with the government. They have been able to… 
recently gain access to take-home doses” of buprenorphine in 
Northeast Indian states such as Manipur and Nagaland (Charanjit). 
• Thanks to activists in Tanzania, in 2011 a methadone programme 
was launched, with an amendment to the drug bill meaning that 
people would receive treatment if found in possession of drugs, a 
“great achievement” (Happy). 
• Activist organisations such as VOCAL NY played a significant role 
in pressuring New York state to expand its Hepatitis C testing law, 
in 2014, and continue to push for treatment access for everyone 
living with Hepatitis C; and “there are other examples of that 
throughout the country” (Robert).
• Since 2016, there have been moves from the Norwegian govern-
ment to decriminalise drug use and shift ‘from punishment to 
help’, thanks to tireless activism from people who use drugs. “The 
Health Minister [Bent Høie] answered us in the media and said, 
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me in and showed me the ropes” (Zoe). This is crucial to ensure 
the sustainability of the movement, helping contribute to an 
“organic transitioning of leaders” (Bikas) rather than an exclu-
sive club. For some participants, training new leaders was the 
top priority from the point of view of sustaining the movement: 
“The first job of every leader is to find more leaders” (Mat). 
Indeed, leaders have generally amassed significant tacit knowl-
edge, expertise and networks, and so when leadership changes, 
there can be big “gaps in communications” and a loss of “insti-
tutional memory” (Simon). 
 Several participants also discussed how much younger advo-
cates have to teach the older generation, suggesting that older 
activists should have “an open arms policy for new ways of think-
ing” (Brun) and listen and be receptive to younger advocates’ 
“drive, passion… and experience” (Angela). Indeed, there was a 
sense from many participants that learning can be a horizontal, 
multi-directional process, rather than a vertical process; activ-
ists need to learn not only from the movement’s leaders, but also 
from those they represent, and all the voices of people who use 
drugs. As one participant said, “Every place is a school, and every 
person is a teacher… listen to the voice of the grassroots, what 
happens on the grassroots level. You cannot avoid their voice” 
(Edo). Participants frequently voiced their admiration for activ-
ists working within contexts where activism by people who use 
drugs is more burgeoning and less well-established, and hoped 
that these newer and older generations could mutually learn from 
and be inspired by each other. One activist was encouraged by 
evidence of knowledge and lessons being shared between different 
areas of the global movement: “When I see now what’s going on 
in Africa, if you see the many user groups organising themselves, 
trained and getting advice from us, that makes me very happy and 
optimistic… We can learn from them now and they don’t have to 
make the same mistakes as we did, and of course they will make 
mistakes, otherwise you don’t learn… We still have a long way to 
go, but we’re getting somewhere” (Tonny).
okay, when all of you oppose criminalisation, then I must be for 
decriminalisation of use and possession” (Arild).
• In a previous iteration of South Africa’s National Strategic Plan, 
there was just one sentence about evidence-based programmes 
for people who use drugs. However, now thanks to activists’ ef-
forts to raise awareness regarding the health of people who use 
drugs, “in the latest plan that will be implemented [from 2017] 
until 2022, for people use drugs, interventions are mentioned; 
needle and syringe programs are mentioned; and human rights 
abuses are mentioned” (Nelson).
• Activists were involved in shaping and producing the Implement-
ing Comprehensive HIV and HCV Programmes with People Who 
Inject Drugs (IDUIT), published in 2017 and adopted as normative 
guidance by the Global Fund. “I think it was unusual in that the 
very process of it, and of developing it, was consultative and did 
involve people who use drugs” (Judy).
• The work of Dan Bigg, who passed away in 2018, to distribute nal-
oxone and thus prevent overdose deaths was mentioned by many 




The 34 participants’ accounts richly demonstrated the overlap-
ping and contrasting lived experiences of activists fighting for 
the rights of people who use drugs around the world. Perhaps 
the most common thread unifying these experiences was a sense 
of collective pride, hope and resilience, even in contexts where 
participants were more pessimistic about the prospect of posi-
tive, meaningful change. The participating activists’ accounts 
illustrated many tensions and fault lines in the movement that 
become intensified due to criminalisation and marginalisation, 
for example between the activist and their family, between advo-
cates working within official, more professionalised systems 
versus those outside, and between and within communities of 
people who use drugs. That said, participants expressed a clear 
determination to remain united, and to rally around a common 
goal of ending prohibition and the failed policy of the ‘War on 
Drugs’. To this end, memorialising and paying tribute to previ-
ous generations of leading activists can inspire newer activists to 
become involved in the movement, and to continue what is often 
an exhausting, emotionally draining fight, given the slow pace 
of change and even in some countries, regressing towards more 
punitive laws and policies. However, many activists recognised 
that change may seem limited in the present, but looking back 
can provide a sense of how far the movement has actually come 
in overcoming challenges and achieving success. Participants 
suggested that it is vitally important to keep the stories of the 
previous generation of activists alive, not only to honour these 
pioneers and empower newer advocates but also to win over 
hearts and minds to the notion of more humane and progressive 
drug policies. Reflecting on the strength of previous activists and 
the movement overall generated a profound sense of hope for 
participants, a belief perhaps that with continued activism, pro-
gress towards ending prohibition and the war on drugs is only a 
matter of time.
 Finally, with the movement having lost many leaders to 
“failed policies” (Robert), participants emphatically spoke of 
“standing on the shoulders of giants”, and discussed how leaders 
in the movement have provided invaluable examples and lessons 
of how to push for change and empowerment in the face of prohi-
bition and oppression. The fact that they “were brave enough to 
risk their life” (Edo) and “came up with terrific, creative ideas” 
(Ann) has inspired activists to “continue their fighting” (Edo) 
in hugely challenging and dangerous situations. Stories of suc-
cess and progress allow people who use drugs to “sit up a little 
taller” (Ann), hence the importance of memorialising and shar-
ing the life stories and pioneering work of activists who have 
gone before. Indeed, remembering specific activists’ unique and 
distinctive approach can be a guide to how to act in the here-and-
now, a reminder to keep those in power “on their toes and doing 
the right thing” (Andria). Memorialisation not only reminds 
activists of the importance of this fight, but is also vital in the 
context of helping address the trauma and bereavement the 
community of people who use drugs has experienced after the 
deaths of so many loved and respected fellow activists. Often, 
activists have achieved a huge amount on behalf of a small, spe-
cific, highly localised community of people who use drugs; they 
are “the unsung heroes of our movement” (Mat) who deserve 
broader recognition. Keeping the stories of these activists alive, 
and using them to inspire and engage people within and outside 
the movement to end the drug war “is the best way we can hon-
our people who’ve gone on, to continuously talk about them, to 
not let their stories die” (Zoe)
The International Network of People who Use Drugs (INPUD) is a 
global peer-based organisation that seeks to promote the health and 
defend the rights of people who use drugs. INPUD will expose and 
challenge stigma, discrimination, and the criminalisation of people who 
use drugs, and its impact on the drug-using community’s health and 
rights. INPUD will achieve this through processes of empowerment and 
advocacy at the international level, while supporting empowerment and 
advocacy at community, national and regional levels. 
www.inpud.net

